CD8A and neoplasm: By immunohistochemical analysis of tumor tissues obtained before combination therapy, we performed immune profiling of the tumor-infiltrated cells and found that good-responders had more tumor-infiltrating CD8+T cells than poor-responders (Fig. 6b, c).